基于二氧化碳-氧气 (CO2 - O2) 衍生指数的急性循环衰竭治疗:Lactel随机多中心研究
Pierre-Grégoire Guinot1, Corentin Evezard1, Maxime Nguyen1
1Department of Anesthesiology and Intensive Care, Dijon University Hospital, Dijon; University of Burgundy, Dijon; Center for Translational and Molecular Medicine (CTM), INSERM UMR1231, Lipness Team, Dijon.
Chest
|November 30, 2024
概括
使用CO2-O2衍生指数的复苏并没有改善ICU患有循环衰竭的ICU患者的乳酸清除. 需要进一步的研究来确定可能从这种方法中受益的潜在患者子组.
科学领域:
- 关键护理医学 关键护理医学
- 血液动力学 血液动力学
- 代谢监测是指对代谢的监测.
背景情况:
- 急性循环衰竭是重症监护病房 (ICU) 中的一个关键病症.
- CO2-O2衍生指数,如中央静脉至动脉CO2差异,用于评估代谢需求和组织缺氧.
研究的目的:
- 为了确定以CO2-O2衍生指数为指导的复苏策略是否与标准护理相比改善了组织低 perfusion.
- 评估对乳酸清除和其他临床结果的影响.
主要方法:
- 一项随机,前性,多中心研究,涉及179名急性循环衰竭和乳酸水平升高的成年患者.
- 患者被分配到基于CO2-O2衍生算法的治疗或标准护理.
- 主要结局是乳酸清除率>10%在2小时内.
主要成果:
- 在对照组 (50%) 和干预组 (43.8%) 之间没有观察到在2小时内实现乳酸清除>10%的显著差异.
- 二次结局,包括败血症相关器官衰竭评估得分,ICU/住院时间长度和28天死亡率,在两组之间没有显著差异.
结论:
- 与标准护理相比,使用CO2-O2衍生指数的算法复苏并没有证明乳酸清除或临床结果有所改善.
- 需要进一步调查以确定可能受益于这种复苏策略的特定患者子组.
相关概念视频
Acute Respiratory Failure-V
123
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
123
Acute Respiratory Failure-IV
126
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
126
Acute Respiratory Failure-III
159
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
159
Acute Respiratory Failure-I
173
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
173
Assessment of Diffusion and Perfusion
909
Understanding and evaluating diffusion and perfusion is critical in assessing a patient's respiratory and circulatory health. These processes play key roles in maintaining the body's internal environment, ensuring that tissues receive adequate oxygen while waste products are efficiently removed.
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this...
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this...
909
Acute Respiratory Failure-II
174
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
174


